Latest News - Research and Publications

Tuesday, August 15, 2017 | Neuromuscular & Immune Disorders, Research and Publications

Gut Bacteria May Play Preventive Role in MS

New findings support the increasingly prominent hypothesis that gut bacteria play a role in autoimmune diseases such as multiple sclerosis (MS). Specifically, a study published in Cell Reports (Aug;20…

Read the full story

Thursday, August 10, 2017 | Healthcare Trends, Research and Publications, Stroke & Cerebrovascular

Stroke Rates Decreasing Among Men, Steady in Women

Although stroke incidence rates are dropping overall, new findings suggest that those decreases are only seen in men. In a new study published in Neurology (published online August 9), investigators t…

Read the full story

Tuesday, July 25, 2017 | Research and Publications, Visual & Sensory Disturbances

Largest CTE Study in Football Players to Date Finds Pathological Diagnosis in 110 out of 111 NFL Players

The already compelling evidence tying football to chronic traumatic encephalopathy (CTE) is now even stronger, with the publication of findings from the largest study yet to evaluate the brains of dec…

Read the full story

Monday, July 17, 2017 | Dementia & Cognitive Disorders, Research and Publications

AAIC 2017: Healthy Diets Tied to Decreased Likelihood of Cognitive Impairment In Older Individuals

The benefits of a healthy diet may extend to cognitive health, according to findings presented at the Alzheimer’s Association International Conference in London. Among nearly 6,000 older adults …

Read the full story

Wednesday, July 12, 2017 | Movement Disorders, Research and Publications

Visual System Changes May Represent an Early Signal of Parkinson’s Disease

Changes in the intracranial visual system may be a signal of Parkinson’s disease (PD), according to new findings published in Radiology. Using MRI, researchers evaluated 21 patients with newly d…

Read the full story

Thursday, July 06, 2017 | Dementia & Cognitive Disorders, Research and Publications, Sleep

Sleep Disturbances Linked to Alzheimer’s Disease

Poor sleep may be a sign that otherwise healthy individuals may have an increased risk of developing Alzheimer’s disease later in life over those who do not have sleep problems, according to a s…

Read the full story

Wednesday, June 14, 2017 | Movement Disorders, Phase 3/4 Trials, Research and Publications

Phase 3 Results Published for Investigational Levodopa-Induced Dyskinesia Treatment

Results from the Phase 3 EASE LID clinical trial, published online in JAMA Neurology, show that the investigational ADS-5102 (amantadine, Adamas Pharmaceuticals) reduces levodopa-induced dyskinesia (L…

Read the full story

Tuesday, June 13, 2017 | Pain & Headache, Phase 3/4 Trials, Research and Publications

AHS 2017: Amgen’s CGRP Inhibitor Reduces Migraine Days

New Phase 2 data show that Amgen’s investigational investigational CGRP inhibitor erenumab is effective at preventing migraine in patients experiencing 15 or more migraine days per month. In a s…

Read the full story

Friday, June 09, 2017 | Movement Disorders, Research and Publications

Anti-Alpha-Synuclein Antibody Shows Early Potential as Parkinson’s DMT

PRX002, an investigational monoclonal antibody, may inhibit cell-to-cell transmission of alpha-synuclein and modify disease progression in Parkinson’s disease (PD), according to a study presente…

Read the full story

Thursday, June 08, 2017 | Pain & Headache, Phase 3/4 Trials, Research and Publications

AHS 2017 Meeting: Prochlorperazine More Effective than Hydromorphone for Acute Migraine

A new comparative study presented at the American Headache Society Annual Meeting in Boston shows that that, in patients who visit the emergency department for acute migraine treatment, prochorperazin…

Read the full story

Thursday, June 08, 2017 | Pain & Headache, Phase 3/4 Trials, Research and Publications

AHS 2017 Meeting: Non-Invasive Medical Devices Show Promise for Severe Headaches

Results from studies presented at the American Headache Society Annual Meeting in Boston suggest that non-invasive medical devices offer effective interventions for individuals with migraine. …

Read the full story

Wednesday, June 07, 2017 | Movement Disorders, Research and Publications

Smartphone Sensor Data Offer Insights Into Daily Functioning in Patients with Parkinson’s Disease

Smartphones are a valuable resource in gaining mobility data in patients with Parkinson’s disease, according to new research presented at the 21st International Congress of Parkinson’s Dis…

Read the full story

Thursday, June 01, 2017 | Pain & Headache, Phase 3/4 Trials, Research and Publications

Teva’s Fremanezumab Reduces Monthly Headache Days in Phase 3 Chronic Migraine Study

    Results from the Phase 3 HALO study suggest that fremanezumab (Teva Pharmaceuticals) reduces the number of monthly headache days in patients with chronic migraine. Fremanezumab is …

Read the full story

Tuesday, May 30, 2017 | Dementia & Cognitive Disorders, Movement Disorders, Research and Publications

Neurodegenerative Diseases Linked by Abnormal Proteins Causing Similar Damage to Brain Cells

Abnormal proteins found in Alzheimer's disease, Parkinson's disease, and Huntington's disease share a similar ability to cause damage when they invade brain cells, according to recently pu…

Read the full story

Friday, May 26, 2017 | Epilepsy & Seizure Disorders, Phase 3/4 Trials, Research and Publications

NEJM Publishes Phase 3 Data for Epidiolex in Dravet Syndrome as Manufacturer Eyes Mid-2017 NDA Submission

The New England Journal of Medicine has published results from a Phase 3 study showing that Epidiolex (cannabidiol, GW Pharmaceuticals) reduces monthly convulsive seizure frequency compared to placebo…

Read the full story
Load More